Danaher Corporation (DHR): Price Target and June Short Interest Disclosure

Danaher Corporation (DHR) : The highest level Danaher Corporation (DHR) is projected to reach is $120 for the short term and the lowest estimate is at $81. The consolidated price target from 13 rating analysts who initiate coverage on the stock is $97.31 and the possibility the share price can swing is $11.28.

Danaher Corporation (DHR) has witnessed a rise of 7% or 447,757 shares in its short figure. The short interest augmentation took it from 6,424,118 on June 15,2016 to 6,871,875 on June 30,2016. In terms of floated shares, the short interest was calculated to be 1.1%. The days to cover are 2 given that the daily volume averaged 3,590,529 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Goldman Sachs initiates coverage on Danaher Corporation (NYSE:DHR). Goldman Sachs has a Neutral rating on the shares. As per the latest report, the brokerage house announces the price target to $74 per share. The rating by the firm was issued on July 5, 2016.


Danaher Corporation (NYSE:DHR): On Thursdays trading session , Opening price of the stock was $81.72 with an intraday high of $81.7972. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $80.66. However, the stock managed to close at $80.88, a loss of 0.20% for the day. On the previous day, the stock had closed at $81.04. The total traded volume of the day was 2,916,325 shares.

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.